rs786204855
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_000314.8(PTEN):c.139A>G(p.Arg47Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★★).
Frequency
Consequence
NM_000314.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.139A>G | p.Arg47Gly | missense_variant | Exon 2 of 9 | ENST00000371953.8 | NP_000305.3 | |
PTEN | NM_001304717.5 | c.658A>G | p.Arg220Gly | missense_variant | Exon 3 of 10 | NP_001291646.4 | ||
PTEN | NM_001304718.2 | c.-567A>G | 5_prime_UTR_variant | Exon 2 of 9 | NP_001291647.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
PTEN hamartoma tumor syndrome Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects PTEN function (PMID: 25429968). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 47 of the PTEN protein (p.Arg47Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with PTEN-related conditions (PMID: 11494117; Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 189401). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (Invitae) indicates that this missense variant is expected to disrupt PTEN function. -
PTEN c.139A>G (p.Arg47Gly) meets criteria to be classified as pathogenic for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (PMID 30311380). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column). PS2: De novo (both maternity and paternity confirmed) observation in a patient with the disease and no family history. (internal laboratory contributor(s) ClinVar Organization ID: 26957) PS3: Phosphatase activity <50% of wild type (PMID 20538496, 25429968, 29706350) PM2: Absent in large sequenced populations (PMID 27535533) PP2: PTEN is defined by the PTEN Expert Panel as a gene that has a low rate of benign missense variation and where missense variants are a common mechanism of disease. PS4_P: Proband(s) with phenotype specificity score of 1-1.5. (internal laboratory contributor(s) ClinVar Organization ID: 26957) -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.R47G pathogenic mutation (also known as c.139A>G), located in coding exon 2 of the PTEN gene, results from an A to G substitution at nucleotide position 139. The arginine at codon 47 is replaced by glycine, an amino acid with dissimilar properties. Functional assays demonstrated reduced phosphatase activity for p.R47G compared to wild type PTEN (Wang Q et al. J. Mol. Graph. Model., 2010 Aug;29:102-14; Wei Y et al. J. Biol. Chem., 2015 Jan;290:1592-606; Mighell TL et al. Am. J. Hum. Genet., 2018 05;102:943-955). In addition, this alteration was reported in a cohort of 21 families with Cowden or Bannayan-Riley-Ruvalcaba syndrome in a family with GI polyps, multiple fibroadenomas of the breast, Hashimoto's thyroiditis and goiter, lipomas, and papules of the oral mucosa (Marsh DJ et al. Neoplasia;3:236-44). This variant has also been identified, one of which was a de novo occurrence, in children with clinical features of PTEN hamartoma tumor syndrome including penile freckling and/or macrocephaly with developmental delay (Ambry internal data). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at